申请人:Scios Nova Inc.
公开号:US05250537A1
公开(公告)日:1993-10-05
5,6,7,8,9,10-Hexahydro-7,10-iminocyclohept[b]indole, 6,7,8,9,10,11-hexahydro-7,11-imino-5H-cyclooct[b]indole and substituted derivatives are effective in the treatment of psychoses with limited liability to produce concomitant adverse extrapyramidal symptoms. These compounds are also useful for treating other central nervous system and cardiovascular disorders.
5,6,7,8,9,10-六氢-7,10-亚胺环庚[b]吲哚,6,7,8,9,10,11-六氢-7,11-亚胺-5H-环辛[b]吲哚及其取代衍生物在治疗精神病时具有效性,且对产生并发不良的外周运动障碍症状的风险有限。这些化合物也适用于治疗其他中枢神经系统和心血管疾病。